The hidden research system: The evolution of cytogenetic testing in the national health service

Science as Culture

Volumn 15, Issue 3, 2006, Pages 253-276

  Hopkins, Michael M ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34548563099     PISSN: 09505431     EISSN: 14701189     Source Type: Journal    
DOI: 10.1080/09505430600890701     Document Type: Article

References (50)

1. Adinolfi, M., and Sherlock, J., 2001. Fetal cells in transcervical samples at an early stage of gestation. Journal of Human Genetics, 46:99–104.
2. Berggren, U., 1985. CT scanning and ultrasonography:a comparison of two lines of development and dissemination. Research Policy, 14:213–223.
3. Bianchi, D., 1998. Fetal DNA in maternal plasma:the plot thickens and the placental barrier thins. American Journal of Human Genetics, 62:763–764.
4. Bijker, W. E., 1995. Of Bicycles, Bulbs, and Bakerlite, Towards a Theory of Social Change, Cambridge, MA:The MIT Press.
5. Blume, S., 1992. Insight and Industry:On the Dynamics of Technical Change in Medicine, Cambridge, MA:MIT Press.
6. Casper, M., and Clarke, A., 1998. Making the Pap smear the ‘right tool’ for the job. Social Studies of Sciences, 28 (2):255–290.
7. Chamberlain, J., 1978. Human benefits and costs of a national screening programme for neural tube defects. Lancet, 1978 (2):1293–1297.
8. Coventry, P., 2000. “ The dynamics of medical genetics:the development and articulation of clinical and technical services under the NHS, especially at Manchester c. 1945–1979 ”. PhD Thesis, Faculty of Science and Engineering, University of Manchester
9. Dyer, C., 2004a. Pressure mounts for inquiry into MMR furore. British Medical Journal, 328 (28 February):483
10. Dyer, C., 2004b. Human error and systems failure caused IVF mix up. British Medical Journal, 328 (26 June):1518
11. Fergerson-Smith, M., Benson, P., Brock, D., Fairweather, D., Harris, R., Laurence, K., McDermott, A., Patrick, A., Polani, P., and Walker, S., 1978. “ The provision of services for the prenatal diagnosis of fetal abnormality in the United Kingdom ”. In Bulletin of the Eugenics Society, Clinical Genetics Society (UK. Supplement No.3 to the
12. Finkelstein, S. N., and Gilbert, D. L., 1985. Scientific evidence and the abandonment of medical technology:a study of eight drugs. Research Policy, 14:225–233.
13. Fitzsimmons, J., Baraitser, M., Davidson, B., Fergerson-Smith, M., Nevin, N., and Pembrey, M., 1982. “ The provision of regional genetic services in the United Kingdom ”. In Bulletin of the Eugenics Society, Clinical Genetics Society (UK. Supplement No.4 to the
14. Fleck, J., 2000. “ Artefact-activity:the co-evolution of artefacts, knowledge and organisation in technological innovation ”. In Technology as an Evolutionary Process, Edited by:Ziman, J., 248–266. Oxford:Oxford University Press.
15. Gassmann, O., Reepmeyer, G., and von Zedtwitz, M., 2004. Leading Pharmaceutical Innovation:Trends and Drivers for Growth in the Pharmaceutical Industry, Berlin:Springer-Verlag.
16. Gelijns, A., 1990. “ Comparing the development of drugs, devices and procedures in medicine ”. In Modern Methods of Clinical Investigation, Edited by:Gelijns, A. C., 147–201. Washington, DC:National Academy Press.
17. Gelijns, A., and Rosenberg, N., 1994. The dynamics of technological change in medicine. Health Affairs,:28–46.
18. Haddow, J., 1998. Commentary:antenatal screening for Down's syndrome:where are we and where next?. The Lancet, 352 (1 August):336–337.
19. Hagard, S., and Carter, F., 1976. Preventing the births of infants with Down's syndrome:a cost benefit analysis. British Medical Journal, 1 (27 March):753–756.
20. Harris, H., 1995. The Cells of the Body, New York:Cold Spring Harbor Laboratory Press.
21. Harris, R., and Reid, M., 1997. Medical genetic services in 31 countries:an overview. European Journal of Human Genetics, 5 (Supplement 2):3–21.
22. Hicks, D., and Katz, J., 1996. Hospitals:the hidden research system. Science and Public Policy, 23 (5):297–304.
23. Hopkins, M., 2004. “ Technique-led technological change and the hidden research system:genetic testing services in the NHS ”. DPhil Thesis, SPRU, University of Sussex
24. Hughes, A., 1964. Some historical features in cell biology. International Review of Cytology, 1 (1):1–6.
25. Isaacs, A., Daintith, J., and Martin, E., 1991. Concise Science Dictionary, Edited by:Isaacs, A., Daintith, J., and Martin, E., Oxford:Oxford University Press.
26. Jackson, T., 2001. Gods and monsters. British Medical Journal, 322 (10 February):371
27. Jankowski, J., and Polak, J., 1996. Clinical Gene Analysis and Manipulation, Edited by:Jankowski, J., and Polak, J., Cambridge:Cambridge University Press.
28. Judson, H., 1992. “ A history of the science and technology behind gene mapping and sequencing ”. In The Code of Codes:Scientific and Social Issues in the Human Genome Project, Edited by:Kevles, D., and Hood, L., 37–80. Cambridge, MA:Harvard University Press.
29. Kevles, D., 1985. In the Name of Eugenics:Genetics and the Uses of Human Heredity, New York:Knopf.
30. Klein, R., 1989. The Politics of the NHS, London:Longman.
31. Le Fanu, J., 1999. The Rise and Fall of Modern Medicine, New York:Carroll and Graf Publishers.
32. MacKenzie, D., and Wajcman, J., 1999. The Social Shaping of Technology, Edited by:MacKenzie, D., and Wajcman, J., Buckingham, PA:Open University Press.
33. Mann, K., Fox, S., Abbs, S., Ching, S., Scriven, P., Docherty, Z., and Ogilvie, C., 2001. Development and implementation of a new rapid aneuploidy diagnostic service within the UK National Health Service and implications for the future of prenatal diagnosis. The Lancet, 358 (29 September):1057–1061.
34. Mansfield, E., 1993. Diagnosis of Down's syndrome and other aneuploidies using qualitative polymerase chain reaction and small tandem repeat polymorphisms. Human Molecular Genetics, 2:43–50.
35. Martin, P., 1998. From Eugenics to Therapeutics:Science and the Social Shaping of Gene Therapy, Brighton:SPRU University of Sussex.
36. Nelis, A., 1999. Managing genetic testing:the relative powerlessness of actors in stable practices. New Genetics and Society, 18 (2/3):125–143.
37. Polani, P., 1997. Human and clinical cytogenetics:origins, evolution and impact. European Journal of Human Genetics, 5:117–128.
38. Porter, R., 1999. The Greatest Benefit to Mankind, London:Fontana Press.
39. Rapp, R., 2000. Testing Women, Testing the Fetus:The Social Impact of Amniocentesis in America, London:Routledge.
40. Reid, M., 1991. The Diffusion of Four Prenatal Screening Tests Across Europe, London:King's Fund Centre.
41. Rodeck, C., 2000. “ The James Young Simpson Oration 2000:an intrauterine odyssey ”. Regents Park College. personal communication from the author
42. Rose, P., and Lucassen, A., 1999. Practical Genetics for Primary Care, Oxford:Oxford University Press.
43. Shaw, B., 1998. Innovation and new product development in the UK medical equipment industry. International Journal of Technology Management,:433–445. (Special issue on management of technology in healthcare)
44. Trask, B., 2002. Human cytogenetics:46 chromosomes, 46 years and counting. Nature Reviews Genetics, 3:769–778.
45. UK NEQAS. 1983–2001. Annual Reports National External Quality Assessment Scheme in Clinical Cytogenetics
46. Von Hippel, E., and Tyre, M., 1995. How learning by doing is done:problem identification in novel process equipment. Research Policy, 24:1–12.
47. Wald, N., Kennard, A., Hackshaw, A., and McGuire, A., 1998. Antenatal screening for Down's syndrome. Health Technology Assessment, 2 (1)
48. Wald, N., Rodeck, C., Hackshaw, A., Walters, J., Chitty, L., and Mackinson, A., 2003. First and second trimester antenatal screening for Down's syndrome:the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technology Assessment, 7 (11)
49. Winner, L., 1977. Autonomous Technology:Technics Out of Control as a Theme for Political Thought, Cambridge, MA:MIT Press.
50. Wolf, N., 2002. Misconceptions, London:Vintage.